Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Cabiralizumab
Trade Name
Synonyms FPA008|FPA-008|FPA 008|BMS-986227
Drug Descriptions

Cabiralizumab (FPA008) is a monoclonal antibody that targets the ligand-binding domain of CSF1R (PMID: 26051995).

DrugClasses CSF1R Antibody 5
CAS Registry Number 1613144-80-1
NCIT ID C123831


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BMS-986253 + Cabiralizumab BMS-986253 Cabiralizumab 0 0
Cabiralizumab Cabiralizumab 0 2
Cabiralizumab + Carboplatin + Nivolumab + Paclitaxel Cabiralizumab Carboplatin Nivolumab Paclitaxel 0 1
Cabiralizumab + Fluorouracil + Irinotecan + Leucovorin + Nivolumab Cabiralizumab Fluorouracil Irinotecan Leucovorin Nivolumab 0 1
Cabiralizumab + Gemcitabine + Nab-paclitaxel + Nivolumab Cabiralizumab Gemcitabine Nab-paclitaxel Nivolumab 0 1
Cabiralizumab + Gemcitabine + Nivolumab Cabiralizumab Gemcitabine Nivolumab 0 1
Cabiralizumab + Nivolumab Cabiralizumab Nivolumab 0 8
Cabiralizumab + Nivolumab + Sotigalimab Cabiralizumab Nivolumab Sotigalimab 0 1
Cabiralizumab + Sotigalimab Cabiralizumab Sotigalimab 0 1

Additional content available in CKB BOOST